Incyte (INCY) Interest Expenses (2010 - 2026)
Incyte (INCY) posted Interest Expenses of $6.4 million for Q1 2026, up 999.66% on a QoQ basis from $582000.0 in Q4 2025, and up 10.34% year-over-year from $5.8 million in Q1 2025.
Incyte (INCY) Interest Expenses (2010 - 2026) Analysis & Trends
Incyte's Interest Expenses history runs 17 years deep, the most recent figure standing at $6.4 million for Q1 2026.
- Quarterly Interest Expenses rose 10.34% year-over-year to $6.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.5 million (up 589.63% YoY) and the FY2025 annual result came in at $22.4 million, down 98.95% from the prior year.
- Interest Expenses was $6.4 million for Q1 2026 at Incyte, up from $582000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $17.2 million in Q4 2023 and bottomed at -$13.5 million in Q4 2024.
- A 5-year average of $3.6 million and a median of $5.2 million in 2024 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2022 — Interest Expenses slumped 408.56% — and 2023, when it surged 242.54%.
- Incyte's Interest Expenses stood at -$12.0 million in 2022, then jumped by 242.54% to $17.2 million in 2023, then sank by 178.82% to -$13.5 million in 2024, then jumped by 104.3% to $582000.0 in 2025, then jumped by 999.66% to $6.4 million in 2026.
- Business Quant data shows INCY's Interest Expenses at $6.4 million in Q1 2026, $582000.0 in Q4 2025, and $5.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Incyte | 23.47 Bn | 19.46 Bn | 1.17 Bn | 6.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.40 Mn |
| Mar 31, 2026 | 6.40 Mn |
| Dec 31, 2025 | 582,000.00 |
| Dec 31, 2025 | 582,000.00 |
| Sep 30, 2025 | 5.80 Mn |
| Sep 30, 2025 | 5.80 Mn |
| Jun 30, 2025 | 5.70 Mn |
| Jun 30, 2025 | 5.70 Mn |
| Mar 31, 2025 | 5.80 Mn |
| Mar 31, 2025 | 5.80 Mn |
| Dec 31, 2024 | -13.52 Mn |
| Dec 31, 2024 | -13.52 Mn |
| Sep 30, 2024 | 5.20 Mn |
| Sep 30, 2024 | 5.20 Mn |
| Jun 30, 2024 | 5.20 Mn |
| Jun 30, 2024 | 5.20 Mn |
| Mar 31, 2024 | 5.40 Mn |
| Mar 31, 2024 | 5.40 Mn |
| Dec 31, 2023 | 17.15 Mn |
| Dec 31, 2023 | 17.15 Mn |